Autonomix Medical, Inc.
About Autonomix Medical, Inc.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $0
- Net income
- -$16.7M
- Total assets
- $7.6M
- Market cap
- $4.7M
Source: SEC EDGAR · updated Jun 7, 2026
- Market cap
- $4.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 29, 2024
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Autonomix Medical, Inc..